Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation

Ann Hematol. 2023 Oct;102(10):2955-2957. doi: 10.1007/s00277-023-05298-z. Epub 2023 Jul 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Herpesvirus 4, Human
  • Humans
  • Lymphoma, T-Cell*
  • Pyrazoles / therapeutic use
  • Transplantation Conditioning

Substances

  • ruxolitinib
  • Pyrazoles